Friedl-Naderer Johannainsider trades

In SEC Form 4 filings, Friedl-Naderer Johanna is listed as Chief Commercial Officer of Dyne Therapeutics, Inc. (DYN). In the last 90 days, Friedl-Naderer Johanna sold $25.4K of Dyne Therapeutics, Inc. (DYN) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
DYNDyne Therapeutics, Inc.	Chief Commercial Officer	2	Sep 8

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
DYNDyne Therapeutics, Inc.	Sep 8	Sep 8	S	185	$18.88	Sale −$3,493	152,897	Yes	Form 4
DYNDyne Therapeutics, Inc.	Sep 4	Sep 8	S	900	$24.35	Sale −$21,915	153,082	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.